Healthy export chance
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 14 September, 1999 - 22:00
WA’S first integrated biomedical research institute has received a $1 million kick start from the WA Government.
The WA Biomedical Research Institute will draw together a number of the state’s top research bodies to undertake cutting edge research.
It will be jointly operated by Curtin and Murdoch universities and will seek solutions to problems within the health care, medical, pharmaceutical and biotechnology industries.
Commerce and Trade Minister Hendy Cowan said the institute would address issues such as the need for more efficient and effective drugs against antibiotic-resistant disease strains, infectious diseases such as malaria and the needs of an ageing population.
“The institute is a very good investment for this state, providing a foundation for WA’s future in biomedical technology, molecular diagnostics and improved health care for the 21st century,” Mr Cowan said.
“The institute will also bring opportunities for other industries such as pharmaceutical production, agriculture – in fields such as genetic diversity, conservation genetics and parasite resistance – and food processing in the identification and treatment of contamination,” he said.
The WA Biomedical Research Institute will draw together a number of the state’s top research bodies to undertake cutting edge research.
It will be jointly operated by Curtin and Murdoch universities and will seek solutions to problems within the health care, medical, pharmaceutical and biotechnology industries.
Commerce and Trade Minister Hendy Cowan said the institute would address issues such as the need for more efficient and effective drugs against antibiotic-resistant disease strains, infectious diseases such as malaria and the needs of an ageing population.
“The institute is a very good investment for this state, providing a foundation for WA’s future in biomedical technology, molecular diagnostics and improved health care for the 21st century,” Mr Cowan said.
“The institute will also bring opportunities for other industries such as pharmaceutical production, agriculture – in fields such as genetic diversity, conservation genetics and parasite resistance – and food processing in the identification and treatment of contamination,” he said.